Advancements in the treatment of HIV and Aids has improved the prognosis of sufferers, driving insurers to be more inclusive in providing cover, explains Julie Hopkins.
The protection industry should look to offer cover to as many individuals as possible. We have to challenge ourselves to continue to change cultural attitudes and encourage inclusive behaviour. This is why developments in survival of HIV positive individuals have been followed with great interest. Indeed, Hannover Re has been reviewing and analysing the published medical, statistical and research data on HIV and Aids over the past few years. The advent of successful new treatments has given HIV positive individuals a significantly better prognosis. With the new highly active anti-retrovi...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
